drugset / Trial / NCT05666219
Reversal of Complete Heart Block With Aminophylline in Inferior Wall Myocardial Infarction Patients
NaSingle-groupOpen-labelTreatment
Summary
In this study, the investigator will evaluate the rate of reversal of complete heart block with aminophylline in atropine resistant patients with inferior wall myocardial infarction (MI)
Timeline
- Start
- 2022-12-19
- Primary completion
- 2023-12-18
- Completion
- 2025-01-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aminophylline | Small molecule | 240 mg | Intravenous |